CodeMap® 
150 North Wacker Drive
Suite 2360
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2025
2024
QW Tests

Physician Fee Schedule

2025
2024

OPPS Fee Schedule

2025-January
2024-October

ASC Fee Schedule

2025-January
2024-October

APC Codes

2025-January
2024-October

DRG Codes

2025
2024

ASP Drug Pricing Files

2025-January
2024-October


CMS Transmittals



.


 

CodeMap® Compliance Briefing: 3/6/09


Editor's Welcome:

Quantitative assays for both therapeutic drugs and drugs of abuse are often used to monitor patients being treated for acute and chronic pain due to cancer, injuries, musculoskeletal disorder and arthritis. Since some patients self-medicate with other drugs, divert prescription drugs to others, or simply do not take their medications consistently, it has become common to monitor such patients for urine or serum drug levels on a regular basis. Such measurements, commonly performed by HPLC/MS methods, can also be used to adjust dosage levels and detect those patients who are simply non-responsive to a given drug. Today, we will discuss how to code quantitative assays for the narcotic drugs commonly prescribed for pain relief. As always, please let us know via email if you have any questions or comments on this topic.

Sincerely,

Gregory Root, Esq....

Sorry, the full document you are trying to access requires an active subscription.

Please login to the left.


Click here for publications catalog.

--

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.